Sector Definitions

AgBio: These companies focus on using biotechnology to develop or improve biopesticides, plant growth efficiency, crop agriculture and food technologies.
Animal Health Care: The development of various biotechnologies that can be applied to the care of animals including both therapeutics and diagnostics.
Biodefense: A company doing research and development focused towards products to defend against attacks involving biological agents.
Bioinformatics: The use of computers in the life sciences to analyze data including genome/protein sequences, modeling of molecules and biologic systems, development of efficient data analysis and data mining from various information sources to solve biological problems.
Biological Devices: These companies use biologically derived materials to develop biomedical devices which include tissue engineering, drug delivery (i.e., coated stents), wound healing, bio-implants (bone, cartilage, vascular grafts, etc.).
Biomaterials: Materials that are biocompatible with living cells in an attempt to minimize rejection reactions. Biomaterials may have a variety of applications including implants, diagnostic and surgical instruments as well as artificial organs.
Biosensor: A system, device or probe that detects biological function or structure.
Biotechnology: We have referenced the E&Y definition of biotech companies (Global Biotechnology Report) as those that use modern biological techniques to develop products or services for human health care, animal health care, agricultural productivity, food processing, renewable resources, industrial manufacturing and environmental management. In addition, the Florida BioDatabase has included additional biomedical companies (medical device, large pharma, large lab service, etc.) that are not necessarily recognized by the E&Y definition. These companies have significant core biotech activities and are indicated in the Florida BioDatabase as they are an important part of the Florida biotech industry.
Business Threshold: Companies that were included in the Biotech Company Listing satisfied several criteria including a valid business concept with growth and marketplace opportunity defined; an actual technology; intellectual property; management identified; an active web site; and a corporate location apart from a university lab setting. Biotech companies that did not meet these criteria are followed along in a %u201Ctransitional%u201D database until they meet the entry criteria for the Biotech Company Listing.
CMO: A company contracted to perform development and/or manufacturing services in the biopharmaceutical segment. Services vary from preclinical R&D to processing larger volumes for clinical trials and product commercialization.
Delivery: The development of technologies to improve the delivery of various therapeutics. This may involve improving the actual formulation of a specific drug as well as utilizing medical or biological devices to deliver a standard approved drug molecule.
Diagnostics: The identification of specific biological markers that correlate with normal physiology or with specific disease or abnormal processes. Medical devices may also be developed to perform diagnostic functions.
Environmental: These companies utilize/develop biologic processes to diagnose, monitor or treat a variety of environmental conditions including detoxification of waste products, hazardous spills, groundwater treatment and bioassays.
Genomics/Proteomics: This area includes companies that ascertain gene/protein sequencing to study specific gene/protein function in an effort to identify new biological targets and develop unique diagnostic markers or therapeutics.
Imaging: These companies are developing methods to improve the visual display of structure or function of living tissue, organs, cells or other biologic materials for primarily diagnostic purposes.
Industrial: The development of biotechnologies to reduce pollutants and increase the efficiency of various industrial processes including utilization of biodegradable materials.
Marine: The exploration of marine life as a source of bioactive compounds that can be utilized to develop various applications including therapeutics and diagnostics.
Renewable Resources: These companies help to improve energy efficiency and conservation along with reducing pollution by replacing standard fuel sources with biologic alternatives including agricultural based energy resources.
Therapeutics: The development of biomedical products to treat disease entities in humans or animals and may include new drugs or biological devices. Medical devices may also be considered as therapeutics depending on their individual function.